TG Therapeutics Aktie
WKN DE: A1JXW7 / ISIN: US88322Q1085
|
03.03.2025 18:58:23
|
TG Therapeutics Stock Rises 20% On Strong Revenue In Q4
(RTTNews) - TG Therapeutics, Inc. (TGTX) is up 20.41 percent, gaining $6.05 to trade at $36.14 during Monday's trading after reporting fourth-quarter revenue of $108.2 million, a significant increase from $44.0 million a year ago.
The stock opened at $30.40 and has traded between $30.28 and $35.96 today. Volume has reached 6.4 million shares, well above the average of 2.1 million. TG Therapeutics' 52-week range is $12.93 to $36.84.
The company posted net income of $23.3 million, compared to a net loss of $14.4 million in the same period last year.
Der finanzen.at Ratgeber für Aktien!
Wenn Sie mehr über das Thema Aktien erfahren wollen, finden Sie in unserem Ratgeber viele interessante Artikel dazu!
Jetzt informieren!
Nachrichten zu TG Therapeutics Incmehr Nachrichten
|
03.08.25 |
Ausblick: TG Therapeutics legt die Bilanz zum abgelaufenen Quartal vor (finanzen.net) | |
|
04.05.25 |
Ausblick: TG Therapeutics legt Zahlen zum jüngsten Quartal vor (finanzen.net) |
Analysen zu TG Therapeutics Incmehr Analysen
Aktien in diesem Artikel
| TG Therapeutics Inc | 28,61 | -2,89% |
|